TELA Bio grants CEO 500K RSUs, 2.37M options

TELA Bio, Inc. reports that Chief Executive Officer Heather C. Getz received new equity awards on August 3, 2026.

Rhea-AI Filing Summary

TELA Bio, Inc. reports that Chief Executive Officer Heather C. Getz received new equity awards on August 3, 2026. She was granted 500,000 restricted stock units of common stock, increasing her holdings to 505,000 shares. She also received options for 1,365,000 shares at a $0.74 exercise price and 1,005,000 shares at $0.90, both expiring August 3, 2036. The RSUs vest in four equal annual installments beginning August 3, 2027, and each option vests 25% on that date with the remaining 75% vesting monthly over 36 months, subject to continued service.

Insider Trade Summary

Grant/Award: 2,870,000 shares

Grant/Award 3 txns

Insider Getz Heather C

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F2	1,365,000	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy) F2	1,005,000	$0.00	$0.00
Grant/Award	Common Stock F1	500,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 2,370,000 contracts (Direct); Common Stock — 505,000 shares (Direct)

Footnotes (2)

1. F1. These restricted stock units will vest in four equal annual installments beginning on August 3, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.
2. F2. The option vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.

Key Figures

RSUs granted: 500,000 shares Common stock holdings after grant: 505,000 shares Option grant size 1: 1,365,000 shares +5 more

8 metrics

RSUs granted 500,000 shares Restricted stock units of common stock granted to CEO on August 3, 2026

Common stock holdings after grant 505,000 shares Direct common stock position reported following the RSU award

Option grant size 1 1,365,000 shares Stock options (right to buy) granted with a $0.74 exercise price

Option exercise price 1 $0.74 per share Exercise price for 1,365,000 stock options expiring August 3, 2036

Option grant size 2 1,005,000 shares Stock options (right to buy) granted with a $0.90 exercise price

Option exercise price 2 $0.90 per share Exercise price for 1,005,000 stock options expiring August 3, 2036

Initial option vesting 25% on August 3, 2027 Both option grants vest 25% on August 3, 2027, subject to continued service

Remaining option vesting 75% over 36 months Remaining 75% of each option vests in equal monthly installments over 36 months

Key Terms

restricted stock units, Stock Option (Right to Buy), exercise price, expiration date, +1 more

5 terms

restricted stock units financial

"These restricted stock units will vest in four equal annual installments"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 0.7400"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-08-03"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"The option vests 25% on August 3, 2027, with the remaining 75% vesting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did TELA (TELA) CEO Heather C. Getz receive on August 3, 2026?

Heather C. Getz received 500,000 restricted stock units of common stock and two stock option grants for 1,365,000 and 1,005,000 shares. All awards were granted on August 3, 2026, with multi-year vesting schedules tied to continued service.

How many TELA Bio (TELA) RSUs were granted to the CEO in this Form 4?

The CEO was granted 500,000 restricted stock units of TELA Bio common stock. These RSUs vest in four equal annual installments beginning on August 3, 2027, and each installment is contingent on her continued service with the company through the relevant vesting date.

What are the vesting terms of the new RSUs reported for TELA (TELA)?

The 500,000 RSUs granted to the CEO vest in four equal annual installments starting on August 3, 2027. Each annual tranche requires Heather C. Getz to remain in service with TELA Bio through the applicable vesting date to receive the shares.

What are the exercise prices and expiration dates of the new TELA (TELA) stock options?

The CEO received options for 1,365,000 shares at $0.74 per share and 1,005,000 shares at $0.90 per share. Both option grants have an expiration date of August 3, 2036, providing a ten-year term from the grant date.

How do the new TELA Bio (TELA) stock options vest for the CEO?

Each option grant vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over the following 36 months. Vesting for all portions is conditioned on Heather C. Getz’s continued service with TELA Bio.

How many TELA Bio (TELA) common shares does the CEO hold after these grants?

Following the grant of 500,000 restricted stock units, Heather C. Getz is reported to hold 505,000 shares of TELA Bio common stock directly. This figure reflects her position after the August 3, 2026, non-derivative award transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 04:10 PM Accepted by SEC EDGAR 08/05/2026 - 04:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Getz Heather C

(Last) (First) (Middle)

C/O TELA BIO, INC.

1 GREAT VALLEY PARKWAY, SUITE 24

(Street)

MALVERN PENNSYLVANIA 19355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/03/2026		A		500,000(1)	A	$0	505,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.74	08/03/2026		A		1,365,000		(2)	08/03/2036	Common Stock	1,365,000	$0	1,365,000	D
Stock Option (Right to Buy)	$0.9	08/03/2026		A		1,005,000		(2)	08/03/2036	Common Stock	1,005,000	$0	1,005,000	D

Explanation of Responses:

1. These restricted stock units will vest in four equal annual installments beginning on August 3, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.

2. The option vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.

	/s/ Megan Smeykal, Attorney-in-Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)